News & Events

Added to My Toolbox
Removed from My Toolbox
Added to My Toolbox
Removed from My Toolbox
Oct 27, 2016

Aspirin Use Remains Controversial in Patients without Heart Disease

Weighing risks and benefits of daily aspirin for primary prevention of heart disease remains challenging.

While daily aspirin helps prevent heart events, whether it should be widely used in patients without heart disease remains unclear, according to a recent review published in the American Heart Association journal Circulation.

This paper reviewed the latest evidence on both safety and efficacy of aspirin for the primary prevention of heart disease. Primary prevention refers to steps taken to reduce cardiovascular risk and to help delay or even prevent the development of heart disease. Secondary prevention, on the other hand, includes steps taken to prevent future events in patients already living with heart disease.

While the benefit of aspirin is undisputed in patients with heart disease, its use for primary prevention is much more controversial.

Aspirin, which helps thin the blood and prevent blood clots, significantly reduces risk for heart events like heart attack and stroke. However, it also increases risk for bleeding and other potentially serious complications. Balancing these risks and benefits can be challenging, according to authors.

For example, seven recent, large analyses showed that daily aspirin use in patients without heart disease helps reduce risk for heart events by 10–13%. Daily aspirin use was also associated with a small reduction in risk for death in some of these studies.

But these same analyses also showed that aspirin increased risk for major bleeding by 55–69% and increased risk for hemorrhagic stroke by 33–43%. Authors also note that in these studies, the risk of bleeding with aspirin was five times higher in patients with greater cardiovascular risk than those with lower risk.

Authors found similar results when it came to patients with diabetes, who have especially high risk for heart disease. Since patients with diabetes are at increased risk for heart disease, some guidelines recommend aspirin use in this high-risk population. However, authors note that few analyses support these recommendations.

The good news, as authors explain, is that ongoing clinical trials are designed to improve our understanding of aspirin and primary prevention. These results will help guide future guidelines for patients with and without heart disease.

In the meantime, experts recommend using a risk-based approach to identify patients that might benefit most from daily aspirin use, and prescribing the lowest daily dose possible for primary prevention. Together, these strategies can help minimize risk of complications and maximize benefits of daily aspirin use.

Questions for You to Consider

  • How does aspirin help prevent heart attack and stroke?

  • Aspirin helps prevent heart attack and stroke by reducing blood clotting. Although blood clotting is the body’s natural way of healing damaged blood vessels, blood clots can travel to the heart and block major arteries, causing heart attack or stroke. Therefore, those at high risk for heart attack and stroke often take aspirin to help reduce clotting and risk for future cardiac events.
  • What is stroke?

  • Stroke occurs when there is an interruption of the blood supply to the brain. The two types of stroke include ischemic stroke, where the blood supply to the brain is blocked by a blood clot, and hemorrhagic stroke, which occurs when blood vessels rupture and leak blood into the brain. Symptoms of both types of stroke include sudden numbness in the face, arm or leg, confusion, trouble speaking or understanding, trouble with vision, loss of balance or coordination, and severe headache with no known cause. It is crucial that you call 911 immediately upon experiencing any of these symptoms.


Continued Use of Low-Dose Aspirin is Critical for Preventing Heart Events

Stopping aspirin use is linked to 30% increased risk for heart attack, stroke and other heart problems.

Combined Drug Therapy Cuts Risk of Second Heart Attack

Study addresses the benefits of adding blood thinner ticagrelor to a preventive daily aspirin regimen.

Low-Dose Aspirin Safest for Heart Attack Survivors

Study finds low-dose aspirin is just as effective and carries less risk of complications than high-dose aspirin in heart attack patients.

New Decision Tool Helps Refine Blood Thinner Use in Stent Patients

DAPT score helps weigh the risks and benefits of continued dual antiplatelet therapy after stent implantation.

Updated Guidelines for Dual Blood Thinners to Treat Heart Disease

New recommendations help reduce risk of complications and maximize benefits of treatment.

Questions about a drug?